نتایج جستجو برای: pharmacogenomic

تعداد نتایج: 2060  

2015
Marta F. Bustamante Carlos Morcillo-Suárez Sunny Malhotra Jordi Rio Laura Leyva Oscar Fernández Uwe K. Zettl Joep Killestein David Brassat Juan Antonio García-Merino Antonio J. Sánchez Elena Urcelay Roberto Alvarez-Lafuente Lusia M. Villar Jose Carlos Alvarez-Cermeño Xavier Farré Jeannette Lechner-Scott Koen Vandenbroeck Alfredo Rodríguez-Antigüedad Jelena S. Drulovic Filippo Martinelli Boneschi Andrew Chan Jorge Oksenberg Arcadi Navarro Xavier Montalban Manuel Comabella

Objectives:Weaimed to investigate the association between polymorphisms located in type I interferon (IFN)-induced genes, genes belonging to the toll-like receptor (TLR) pathway, and genes encoding neurotransmitter receptors and the response to IFN-b treatment in patients with multiple sclerosis (MS). Methods: In a first or screening phase of the study, 384 polymorphisms were genotyped in 830 p...

Journal: :Topics in HIV medicine : a publication of the International AIDS Society, USA 2005
David W Haas

Pharmacogenomic studies are contributing to our understanding of interindividual differences in response to antiretroviral drugs. Genetic polymorphism in major histocompatibility complex genes predict likelihood of hypersensitivity reactions in persons prescribed abacavir, and perhaps nevirapine. Recent studies have shown that a polymorphisms in the CYP2B6 gene is associated with higher plasma ...

Journal: :Journal of medical economics 2016
D Brixner E Biltaji A Bress S Unni X Ye T Mamiya K Ashcraft J Biskupiak

OBJECTIVE To compare healthcare resource utilization (HRU) and clinical decision-making for elderly patients based on cytochrome P450 (CYP) pharmacogenetic testing and the use of a comprehensive medication management clinical decision support tool (CDST), to a cohort of similar non-tested patients. METHODS An observational study compared a prospective cohort of patients ≥65 years subjected to...

Journal: :Pharmacological research 2009
Jose de Leon

Rapid technological advances in genetics have created conceptual chaos regarding the genetics of drug response. Terms for differing concepts are used interchangeably: pharmacogenetics with pharmacogenomics, personalized medicine with personalized prescription. Biomarker has many definitions. The author prefers the concept of personalized prescription and uses it with implications beyond pharmac...

2006
Bernard Lerer Ronnen H. Segman

The core hypothesis underlying pharmacogenetics is that genetic factors play a significant role in the well-recognized differences between individuals in response to medication and susceptibility to adverse effects. If these genetic factors can be identified and understood, they may serve as predictors to guide clinicians in tailoring medication to the individual patient. Recent developments in...

2017
Aizati N. A. Daud Eefke L. Bergsma Jorieke E. H. Bergman Hermien E. K. De Walle Wilhelmina S. Kerstjens-Frederikse Bert J. Bijker Eelko Hak Bob Wilffert

BACKGROUND Pharmacogenetics is an emerging field currently being implemented to improve safety when prescribing drugs. While many women who take drugs during pregnancy would likely benefit from such personalized drug therapy, data is lacking on the awareness towards pharmacogenetics among women. We aim to determine the level of knowledge and acceptance of formerly pregnant women in the Netherla...

Journal: :Antimicrobial agents and chemotherapy 1976
B R Meyers S Z Hirschman S Yancovitz B Ribner

Sisomicin in doses of 1 mg/kg was administered intramuscularly to 10 healthy volunteers, and 1 week later the same volunteers received sisomicin at the same dose intravenously. A peak serum concentration of sisomicin of 3.08 mug/ml was obtained 1 h after intramuscular injection, and a peak serum concentration of 7.12 mug/ml was achieved 30 min after a 30-min intravenous infusion. The sisomicin ...

2014
Liewei Wang Richard Weinshilboum

Pharmacogenomics is the study of the contribution of inheritance to variation in drug response—variation that can range from a loss of the desired therapeutic effect at one end of the spectrum to an adverse drug reaction at the other (1,2). The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) recently sponsored a workshop on the pharmacogenomics of metformin, the most wi...

2013
Rachel Mills Deepak Voora Bruce Peyser Susanne B Haga

Pharmacogenetic testing refers to a type of genetic test to predict a patient's likelihood to experience an adverse event or not respond to a given drug. Despite revision to several labels of commonly prescribed drugs regarding the impact of genetic variation, the use of this testing has been limited in many settings due to a number of factors. In the primary care setting, the limited office ti...

Journal: :Studies in history and philosophy of biological and biomedical sciences 2006
Adam M Hedgecoe

Most of the literature on pharmacogenetics assumes that the main problems in implementing the technology will be institutional ones (due to funding or regulation) and that although it involves genetic testing, the ethical issues involved in pharmacogenetics are different from, even less than, 'traditional' genetic testing. Very little attention has been paid to how clinicians will accept this t...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید